Bone Marrow Transplant Market
Market Overview
Bone marrow refers to a soft vascular tissue present in the interior part of the long bones. It is comprised to two types of stem cells including mesenchymal and hematopoietic stem cells. Bone marrow is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of fats.
The global bone marrow transplant market is estimated to account for US$ 13,750.7 Mn in terms of value and 121,661 procedures in terms of volume by the end of 2027.
๐๐ก๐ซ๐ข๐ฌ๐ญ๐ฆ๐๐ฌ ๐๐๐ฅ๐ ๐๐ฌ ๐๐ข๐ฏ๐!
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐จ ๐๐ฏ๐๐ข๐ฅ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐ ๐ซ๐จ๐ฆ ๐๐-๐๐% ๐ญ๐ข๐ฅ๐ฅ ๐๐-๐๐๐-๐๐๐๐
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/232
Market Drivers
Growing prevalence of blood cancer and other blood-related diseases is expected to propel the global bone marrow transplant market during the forecast period. According to Leukemia and Lymphoma Society, one person in the U.S. is diagnosed with a blood cancer around every 3 minutes and 176,200 people in the country are expected to be diagnosed with leukemia, lymphoma or myeloma in 2019. Furthermore, continuous research and development activities pertaining stem cell cryopreservation is expected to propel the global bone marrow transplant market growth over the forecast period. For instance, in November 2019, in the study โDetermination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Deviceโ researchers from Harbin Institute of Technology, developed a comprehensive process for determination of membrane transport properties of Jurkat cell, an immortalized line of human acute lymphocyte leukemia cells that is widely used in the study of adoptive cell therapy.
Europe region held dominant position in the global bone marrow transplant market in 2018, accounting for 58.5%ย share in terms of value, followed by North America.
Market Restraint
Lack of reimbursement policies for organ transplantation procedure is expected to restrain growth of the global bone marrow market during the forecast period. Moreover, high cost of bone marrow transplant is also expected to hamper the market growth. The cost of the transplant in Europe and U.S. ranges from US$ 30,000 to US$ 88,000 for a single autologous transplantation to US$ 200,000 or more for a matched unrelated myeloablative allogeneic procedure.
Leukemia treatment type segment in the global bone marrow transplant market was valued at US$ 2,382.6 Mn in 2018 and is expected to reach US$ 3,260.5 Mn by 2027 at a CAGR of 3.5% during the forecast period.
To Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/232
Market Trends
Contiguous R&D activities in the stem cell therapy is one of the major trends in the market. For instance, in December 2019, researchers from azan Federal University, Russia, reported that application of adipose tissue combined with fibrin matrix during the subacute period in ratโs offers significantly higher post-traumatic regeneration compared to similar applications of allogeneic mesenchymal stem cells derived from bone marrow or dental pulp embedded in fibrin matrix.
Moreover, growing adoption of half-matched transplant option is expected to boost the market growth in the near future. In an allogeneic transplant, a patientโs human leukocyte antigen (HLA) tissue type is matched with that of the donor. Patients who do not have a HLA-matched related or unrelated donor can opt for a partially matched or haploidentical related donor.
Competitive Section
Major companies involved in the global bone marrow transplant market are Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.
Key Developments
- Key players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in November 2019, Lonza Group Ltd. partnered with Cryoport, Inc. in the cell and gene therapy field and across Lonza’s ‘vein-to-vein’ delivery network.
- The market is also witnessing entry of new players. For instance, in December 2019, Jasper Therapeutics, Inc. announced the launch of the company with a US$ 35 million total Series A financing. The company is focused on development of its lead product candidate, JSP191 that is designed to replace or reduce the toxicity of chemotherapy and radiation therapy as a conditioning regimen to prepare patients for hematopoietic cell transplant.
For More Information or Query or Customization before Buying, Visit at โ https://www.coherentmarketinsights.com/insight/talk-to-analyst/232
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Application
- Market Snippet, By Region Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Advancements
- Key Highlights
- Epidemiology
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
- Market Dynamics
- Global Bone Marrow Transplant Market, By Treatment Type, 2019 โ 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Myeloma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Myelodysplastic Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Myeloproliferative neoplasms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Aplastic Anemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Solid Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Sickle cell anemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Thalassemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Million and Number of Procedures
- Introduction
- Global Bone Marrow Transplant Market, By End User, 2019 โ 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 โ 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Multi-Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 โ 2027, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837